As a biopharmaceutical company highly specialized in advanced antibody biochemistry and engineering, Creative Biolabs recently has launched a brand new one-stop antibody drug conjugates service, intending to providing customized services that are tailored to meet R&D timeline and budget of their clients.
Antibody drug conjugate (ADC), generally refers to a molecule compound consisting of a desirable monoclonal antibody, an active cytotoxic payload, and a suitable molecular linker, which is considered to be an innovative and cost-efficient therapeutic method of targeting various kinds of cancers and tumors. Benefiting from the comprehensive one-stop service provided by Creative Biolabs, current ADC development can be completed from the starting point-antibody identification to the final destination-creation and evaluation of the ADC, every step of the way.
When it comes to the prospect of conjugation chemistry market, Dr. Monika Müller, Scientific Officer of Creative Biolabs, always maintains an extremely positive attitude and firmly believes that this market has enough potential to move towards a hopeful and promising future. She said that,
‘In this world of profound technological change and rapid knowledge renovation, it is hardly surprising that these existing difficulties thought to be unable to overcome will be gradually handled. The application of antibody drug conjugates services to cancer curing treatment is such a good example to explain what I just said.’
Designing of an ADC is an elaborate process that involves careful planning, meticulous execution, and intensive trouble-shooting. As a professional service provider pioneering in the field of antibody drug conjugate research and development, Creative Biolabs always gives a priority to the product quality during a custom ADC development project.
With Ph.D. level scientists and over a decade of experience in recombinant antibody production, antibody engineering, synthetic chemistry, and bio-conjugation, Creative Biolabs is dedicated to serving the unique needs of clients in ADC development projects by providing customized services that are tailored to meet the R&D timeline and budget.
About Creative Biolabs
Established in 2004, Creative Biolabs is highly specialized in advanced antibody biochemistry and engineering. With more than a decade of exploration and expansion, our current research and service capacity covers the entire new drug discovery and development pipeline, ranging from early discovery, preclinical evaluations, cGMP manufacturing, to clinical trails. As an international cooperation, we have established offices all around the globe with more than 200 well-trained full-time scientists and technicians, who work closely with our customers and research partners to develop new medicines for a better, healthier world.
Company Name: Creative Biolabs
Contact Person: Bella Smith
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States